← All organizations

IDRx, Inc.

For profit

Also known as: IDRx, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Aug 1, 2022

Acquired by GlaxoSmithKline on Jan 10, 2025

Timeline

2020s

Jan 1, 2021
IDRx, Inc.— Founded
Jan 10, 2025
GlaxoSmithKline— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 1 (1 own, 0 via acquisition)

idrx-42

Recent trials (1)

NCT05489237Lead sponsorPhase 1Aug 1, 2022

Details

Founded: Boston, MA, US Jan 1, 2021
Last known activity: Aug 1, 2022